DABIGATRAN Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description An aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amoino group of N-pyridin-2-yl-beta-alanine. The active metabolite of the prodrug dabigatran etexilate, it acts as an anticoagulant which is used for the prevention of stroke and systemic embolism. (Chemical Entities of Biological Interest Ontology, CHEBI_70752)
External Link https://dgidb.org/results?searchType=drug&searchTerms=DABIGATRAN
Similar Terms
Downloads & Tools

Genes

9 interacting proteins for the DABIGATRAN drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
HNRNPC heterogeneous nuclear ribonucleoprotein C (C1/C2) 11.7627
HYOU1 hypoxia up-regulated 1 11.7627
HNMT histamine N-methyltransferase 2.35253
ADK adenosine kinase 1.06933
NQO2 NAD(P)H dehydrogenase, quinone 2 0.691921
F2 coagulation factor II (thrombin) 0.625674
APOB apolipoprotein B 0.490111
CYP3A5 cytochrome P450, family 3, subfamily A, polypeptide 5 0.289246
CYP2D6 cytochrome P450, family 2, subfamily D, polypeptide 6 0.0192515